AzTrials
AzTrials

Satisfaction, PatientQual'AXINCT04305847

Satisfaction Assessment After Axillary Block

An observational study of Satisfaction, Patient, run by Centre Hospitalier Universitaire de Besancon at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Satisfaction assessment at 24 and 48 hours post operatively, after Axillary Brachial Plexus Block for Distal Arm Surgery. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Satisfaction, Patient
What is being tested?
perioperative satisfaction assessment
How many people
200 participants
Where
1 siteFrance
Study dates
1 Sep 2020to 31 Jan 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: patients for whom distal arm surgery was performed under Axillary Brachial Plexus Block in a single university hospital

Who may be able to join

  • patients for whom distal arm surgery was performed under Axillary Brachial Plexus Block

Who cannot join

  • Refusal, inability to consent
  • inability to fill self-administered survey questionnaire
  • pregnancy and breastfeeding
  • surgery > 2 hours
  • second surgical site requiring anaesthesia or analgesia
  • chronic use of analgesia (including opioids) or illegal drugs

Trial locations and contacts

1 site in 1 country.

Francis Berthier, MD contact

0033381218980

f1berthier@CHU-besancon.fr

France1 site, 1 recruiting
  • CHU de Besançon

    Besançon, 25000

    Francis BERTHIER, MD

    Recruiting

Other trials in France

About this study

Official title: Satisfaction Assessment After Axillary Brachial Plexus Block for Distal Arm Surgery

Satisfaction assessment at 24 and 48 hours post operatively, after Axillary Brachial Plexus Block for Distal Arm Surgery.

Read the detailed description

Inclusion after distal Arm Surgery performed under Axillary Brachial Plexus Block.

Satisfaction assessment at 24 and 48 hours post operatively by self-administered survey questionnaire based on different scales: Evan-LR, Net Promotor Score, Satisfaction score.

Being tested
perioperative satisfaction assessment
Keywords
Anaesthesia, regional, axillary brachial plexus block
Medical subject headings
Patient Satisfaction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • perioperative satisfaction assessmentOther

    Satisfaction assessment at 24 and 48 hours post operatively by self-administered survey questionnaire based on different scales: Evan-LR, Net Promotor Score, Satisfaction score.

Study groups in NCT04305847
Study groupRoleWhat they receive
Qual'AXI grouppatients for whom distal arm surgery was performed under Axillary Brachial Plexus Block
Receives: Other: perioperative satisfaction assessment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Evan-LR score on day 2

    self administrated Evan-LR: "Evaluation du Vécu de l'Anesthésie LocoRégionale" 0-to-100 scale, with "100" indicating the best possible level of satisfaction and "0" the worst.

    Measured: at 48 hours postoperative

Secondary outcomes (5)
  1. Evan-LR score on day 1

    self administrated Evan-LR: "Evaluation du Vécu de l'Anesthésie LocoRégionale" 0-to-100 scale, with "100" indicating the best possible level of satisfaction and "0" the worst.

    Measured: at 24 hours postoperative

  2. Net Promotor score on day 2

    self administrated Net Promotor score: willingness to advise a relative to undergo the same operation on a scale from 0 to 10. Based on the score, patients are divided into promoters (9 or 10), passives (7 or 8), and detractors (under 6). The NPS is determined as follows: NPS = % promoters - % detractors

    Measured: at 48 hours postoperative

  3. Net Promotor score on day 1

    self administrated Net Promotor score: willingness to advise a relative to undergo the same operation on a scale from 0 to 10. Based on the score, patients are divided into promoters (9 or 10), passives (7 or 8), and detractors (under 6). The NPS is determined as follows: NPS = % promoters - % detractors

    Measured: at 24 hours postoperative

  4. Patient Satisfaction score on day 2

    self administrated Satisfaction score: scale from 0 to 10. A score of "0" meant extremely dissatisfied and that a score of "10" meant extremely satisfied

    Measured: at 48 hours postoperative

  5. Patient Satisfaction score on day 1

    self administrated Satisfaction score: scale from 0 to 10. A score of "0" meant extremely dissatisfied and that a score of "10" meant extremely satisfied

    Measured: at 24 hours postoperative

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Mar 2020
  2. Study start1 Sep 2020
  3. Primary completion31 Jan 2021 (estimated)
  4. Study completion31 Jan 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Retrospective
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04305847
Sponsor's protocol ID
P/2020/480
Acronym
Qual'AXI
Status last verified
Dec 2020
First submitted
20 Feb 2020
Last updated
21 Dec 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: Individual Participant Data (IPD) Sharing Statement depending on the institutional modality under development

Questions about this trial

What is this clinical trial studying?

An observational study of Satisfaction, Patient, run by Centre Hospitalier Universitaire de Besancon at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 21 Dec 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Francis Berthier, MD (0033381218980, f1berthier@CHU-besancon.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Evan-LR score on day 2 (time frame: at 48 hours postoperative). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Dec 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in